Intravenous immunoglobulin (IVIG) therapy in pregnancies complicated by acute Parvovirus B19 infection in the second trimester: a case series
IVIG may be useful for Parvovirus B19 treatment in patients with erythropoietic suppression, in patients who decline PUBS/IUT with elevated MCA-PSV, and in patients who have difficult access to the placental cord insertion site, unsuccessful attempt at PUBS, or relative contraindications (i.e. significant abdominal surgery, high BMI).
Authors
- Cassandra Heiselman (ORCID: https://orcid.org/0000-0002-4027-1337)
- Cecilia Avila (ORCID: https://orcid.org/0000-0002-3564-7723)
- David Garry (ORCID: https://orcid.org/0000-0002-5398-7596)
- Rachel Lee (ORCID: https://orcid.org/0000-0003-2322-3664)
- Tiffany Yang (ORCID: https://orcid.org/0000-0002-9687-6669)
- Zenobia Gonsalves
- Jennifer Choi (ORCID: https://orcid.org/0000-0001-8218-4007)
- Elizabeth Garduno
- James Bernasko (ORCID: https://orcid.org/0000-0001-8074-7996)
- Emily H. Stetler
- Kimberly Herrera
Institutions
- Stony Brook University Hospital (US)
Publication Details
- Journal
- Case Reports in Perinatal Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1515/crpm-2025-0010
- Primary Topic
- Parvovirus B19 Infection Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00